Fig. 6
From: Novel neutralizing SARS-CoV-2-specific mAbs offer detection of RBD linear epitopes
The neutralization percent of anti-rRBD mAbs. The purified mAbs (2B4-G11, 1D9-D1, 1G1-G9, 2E7-D2, and 2B4-G8). Measurement of mAbs neutralization activity using rRBD a, b, c, d, e and eukaryotic RBD f, g blocking ELISA assay